Try our beta test site
2 studies found for:    Pierre Morel Waldenstrom's
Show Display Options
Rank Status Study
1 Recruiting Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia
Condition: Waldenström's Macroglobulinemia
Interventions: Drug: Dexamethasone, Rituximab, Cyclophosphamide;   Drug: Dexamethasone, Rituximab, Cyclophosphamide, Bortezomib
2 Active, not recruiting Study of Lenalidomide in Relapse/Refractory Waldenstrom Macroglobulinemia
Condition: Waldenstrom Macroglobulinemia
Intervention: Drug: Revlimid

Study has passed its completion date and status has not been verified in more than two years.